Congenital Pseudarthrosis of Tibia
6
1
1
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
16.7%
1 terminated out of 6 trials
0.0%
-86.5% vs benchmark
17%
1 trials in Phase 3/4
0%
1 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (6)
A Study to Assess How Effective and Safe NVD003 is for Treating Patients With Congenital Pseudarthrosis of the Tibia.
NVD-003 in the Treatment of Congenital Pseudarthrosis of the Tibia
A Study of INFUSE Bone Graft (BMP-2) in the Treatment of Tibial Pseudarthrosis in Neurofibromatosis Type 1 (NF1)
A Retrospective Study of Surgical Treatment of Congenital Pseudarthrosis of Tibia in China
The Effect of Combined Surgery in Management of Congenital Pseudarthrosis of Tibia
The Effect of Percutaneous Kirschner Wire Technique in Management of CPT Under One Year Old